Angiotargeting
Solid tumour growth depends on a continuous supply of nutrients supplied by blood vessels generated within the tumour.
Main content
The importance of tumour angiogenesis has fuelled research into potential therapeutic targets with anti-angiogenic properties. Within the Angiotargeting Consortium, we apply high throughput proteomics technologies to identify novel drug targets and biomarkers involved in the angiogenic switch in malignant brain tumours.
Angiotargeting
29.11.2010